(Reuters) – The U.S. Food and Drug Administration on Friday approved GlaxoSmithKline’s Boostrix vaccine for use during the third trimester of pregnancy to prevent whooping cough in infants younger than two months of age.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Shailesh Kuber)
